Many women have ovarian cysts at some time. Most ovarian cysts present little or no discomfort and are harmless. The majority disappears without treatment within a few months. However, ovarian cysts â especially those that have ruptured â can cause serious symptoms.
Aranesp is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Aranesp is considered a distinct molecular entity from scientific, clinical, legal, and regulatory perspectives..  There is no evidence that Aranesp promotes tumor progression in preclinical studies.  EPO-R detection on non-hematopoietic cells and tumor cells does not correlate well with EPO-R function.